Approximately one-fifth of patients are not satisfied with total knee arthroplasty (TKA). Preoperative variables associated with poorer outcomes are severity and chronicity of pain and psychological disease, which may present as anxiety and depression. It is unclear whether this is constitutional or the result of knee pain. To address this, we explored the association of anxiety and depression with knee disability before and after TKA. Forty patients undergoing TKA completed Hospital Anxiety and Depression Scale (HADS) and Oxford Knee Scores (OKS) preoperatively and at three and six months postoperatively. Both were elevated preoperatively and improved significantly post-operatively (P<0.001). The severity of preoperative anxiety and depression was associated with worse knee disability (coefficient −0.409, p=0.009). Postoperatively reduction in anxiety and depression was associated with improvement in knee disability after three (coefficient −0.459, p=0.003) and six months (coefficient −0.428, p=0.006). The difficulty in interpreting preoperative anxiety and depression and the outcome of TKA is establishing whether they are the cause or effect of pain in the knee. As anxiety and depression improves with knee pain and function, this study suggests that knee pain contributes to the psychological symptoms and that a successful TKA offers an excellent chance of improving both.
Venous thromboembolism deterrent (TED) stockings are recommended for all orthopaedic patients. Clinical evidence supporting their use is limited and the risk of DVT increases four-fold if pressure gradients are reversed. This study aims to investigate the efficacy of TED stockings and their application using pressure gradients as the outcome measure. We audited TED stockings over two discrete periods. In the first, cases were assessed for sizing, cutting in and tolerance. In the second we added pressure measurements along the saphenous vein; before and 2 and 3 days after surgery. Between the 2 series, a more rigorous sizing and re-sizing protocol was implemented.Background
Methods
Resurfacing hip arthroplasty is a successful option for the treatment of the young and active patient with hip arthritis. However, it is complicated by femoral neck fracture and avascular necrosis, which result from devascularisation during surgery. Devascularisation maybe caused by thermal necrosis. Thermal necrosis of bone has been shown to occur in temperatures of 47°C and above. We investigated the temperatures generated during femoral head preparation to see if the temperatures reached were great enough to induce osteonecrosis.
We have determined the 10 year life expectancy of 5,831 patients who had undergone 6,653 elective primary total hip replacements (THR) at a regional orthopaedic centre between April 1993 and October 2004.
The standard mortality rates were significantly higher than expected for patients under 45 years, 20% higher for those between 45 and 64 years and progressively less than expected for patients aged 65 and over.
We determined the 10 year life expectancy of 5,831 patients who had undergone 6,653 elective primary total hip replacements (THR) at a regional orthopaedic centre between April 1993 and October 2004. Using Hospital, General Practitioner (GP) and the local health authority’s records, we determined dates of deaths for all those who had undergone surgery during this period. The mean age at operation was 73 (13–96) with a male to female ratio of 2:3. Of those with 10 year follow up 29.5% had died a mean of 5.6 (0–11.1) years after surgery. Using Kaplan Meier curves, 10-year survivorship was 89% in patients under 65 years at surgery, 75% in patients aged between 65 – 74 years and 51% in patients over 75. The standardised mortality rates (SMR) were significantly higher than expected for patients under 45 years, 20% higher for those between 45 and 64 years and progressively less than expected for patients aged 65 and over. The survivorship of cemented hip arthroplasties (derived from the Swedish Arthroplasty Register 2004) exceeds patients’ life expectancy in those over the age of 60 in our area suggesting that this is the procedure of choice in this population.
We sought to establish whether HEMI or THA gave better results in independent mobile patients with displaced femoral neck fracture.
After THA, three patients died, three dislocated, one required revision. Mean walking distance was 2.23 miles and OHS was 18.8. There was no radiological evidence of polyethylene wear Patients with THAs after three years walked further (p=0.039) and had a lower OHS (p=0.033).
THA is a preferable option to HEMI in independent mobile elderly patients with displaced intracapsular femoral neck fracture.
The aim of this study was to determine the outcome of total hip arthroplasty, with regard to dislocation, at our unit. 1727 primary total joint arthroplasties and 305 revision total hip arthroplasties were performed between 1993 and 1996 at our unit. We followed up 1567 of the primary hip arthroplasties and 284 of the revision hip arthroplasties at 8 to 11 years post surgery. Patients were traced by postal questionnaire, telephone interview or examination of case notes of the deceased. The dislocation rates by approach were: 23 out of 555 (4.1%) for the posterior approach, 0 out of 120 (0%) for the Omega approach and 30 out of 892 (3.4%) for the modified Hardinge approach. 58.5% of dislocations after primary total hip arthroplasty were recurrent. The mean number of dislocations per patient was 2.81. 8.1% of revision total hip arthroplasties suffered dislocation. 70% of these became recurrent. The mean number of dislocations per patient was 2.87. The vast majority of dislocations occur within 3 months of surgery. To our knowledge this is the largest multisurgeon audit of dislocation after total hip arthroplasty published in the United Kingdom. The follow-up of 8 to 11 years is longer than most comparable studies.
Thickness (mm)
Stiffness (Nm / Degree)
1
58 +/− 4
2
37 +/− 1
3
39 +/− 1
4
25 +/− 0.3
5
24 +/− 0.3
The rate of deep infection following primary joint replacement has reduced to below 1%, but the cost remains high. The surgical team is the most important source of bacteria causing infection. All surgical gowns are susceptible to penetration by these organisms, which may then spread to the wound via the surgeon’s hands or contact with wet drapes without ever being airborne. There is insufficient clinical data on the penetration of bacteria through surgical gowns, in part due to the difficulty of There was a significant difference between the two gown types when tested in the axilla (p <
0. 05), the groin (p <
0. 05) and the peri-anal region (p <
0. 01), with the disposable gowns performing to a higher standard. Re-usable gowns demonstrated significant variation in penetrability. This is most likely to be due to the number of laundering and sterilisation cycles that they had undergone. Unless the continued satisfactory performance of multiple-use gowns can be guaranteed, they may be unsuitable for use in orthopaedic implant surgery.
Aseptic loosening of the acetabular component is the main reason for revision hip arthroplasty surgery with loosening rates reported at 25% at 12–15years. The optimum method of acetabular preparation and cementation technique has not been fully evaluated. Clinical follow-up studies suggest multiple keyholes improve survival rates. Keyholes increase penetration of cement and torsional resistance of the bone-cement interface. Some studies support the traditional three 1/2 inch keyholes other studies have shown multiple smaller holes improve stability. The optimum size and number of holes to provide the strongest fixation has yet to be determined. Using an established 54mm diameter acetabular model, mahogany, three sizes of keyhole were tested-3x10mm holes, 12x5mm, and 48x2.5mm- the surface area of the defects created were the same in each group. The model acetabulum was filled with cement and a metal central bar inserted through which torque could be applied using an Instron machine. Six specimens from each group were tested. Three 10mm holes produced a significantly stronger resistance to torque when compared to 2.5mm (p≤0.017) and 5mm holes (p≤0.001). There was no significant difference between 2.5mm and 5mm holes (p≤0.139). Each addition of a further 10mm hole significantly increased the torque strength until the model was destroyed at six holes. In laboratory testing larger key holes provide a stronger cement-acetabular interface.
Twelve patients undergoing total hip replacements were given 600mg linezolid as a 20min intravenous infusion along with conventional prophylaxis of 1gm cefamandole immediately before surgery. Routine total hip arthroplasty was performed and at timed intervals during surgery, samples of bone, fat, muscle and blood were collected for assay by HPLC analysis. Samples of haematoma fluid that formed around the operation site and further blood samples were also collected at timed intervals following the operation for assay. The penetration of linezolid into bone was rapid with mean levels of 9.1mg/L (95% CI: 7.7–10.6mg/L) achieved at 10min after the infusion, decreasing to 6.3mg/L (95% CI: 3.9–8.6mg/L) at 30min. Correcting for the simultaneous blood concentrations gave values for bone penetration of 51% at 10min, 60% at 20min and 47% at 30min. although the penetration of linezolid into fat was also rapid, mean levels and degree of penetration were approximately 60% of those seen in bone at 10min: 4.5mg/L (95%CI:3–6.1mg/L; penetration 27%) 20min: 5.2mg/L (95% CI:4–6.4mg/L; penetration 37%) and 30min:4.1mg/L (95% CI:3.3–4.8mg/L; penetration 31%). For muscle, the corresponding values were 10min: 10.4mg/L (95%CI:8.1–12.7mg/L; penetration 58%), 20min 13.4mg/L (95%:10.2–16.5mg/L; penetration 94%) and 30min 12mg/L (95% CI:9.2–14.8mg/L; penetration 93%). Mean concentration of linezolid in the haematoma around the operation site were 8.2mg/L at 6–8h and 5.6mg/L at 8–10h after the infusion and 7mg/L at 2–4h following a second 600mg infusion given 12h postoperatively. We conclude that linezolid exhibits rapid penetration in bone, fat and muscle of patients undergoing hip arthroplasty to achieve levels in excess of the MIC for sensitive organisms (MIC of <
_ 4mg/L); with therapeutic levels maintained in the drainage which surrounds the operation site for more than 16h. This pharmaco-kinetic profile is similar to those of agents currently used for the treatment of bone and associated soft tissue infections and suggests a role for linezolid in the management of such patients